STRATA Skin Sciences to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Rhea-AI Summary

STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced its participation in the Inaugural Gilmartin Group Emerging Growth Company Showcase on August 31, 2022, at 3:30 PM ET. The event will be virtual, and management will present innovative advancements in dermatologic treatment technologies. Interested individuals can access the presentation via a live webcast through a provided link, with an archived version available on the company’s website post-event. STRATA focuses on developing treatments for conditions such as psoriasis and acne, impacting millions across the U.S.

HORSHAM, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 3:30 PM ET.

Interested parties can access a live webcast of the presentation directly by following this link. An archived webcast of the presentation will be available on the “Investors” section of STRATA Skin Sciences website at www.strataskinsciences.com following the event.

Those parties interested in registering for the Inaugural Gilmartin Group Emerging Growth Company Showcase may do so by following this link.

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the in-office treatment of dermatologic conditions. Its products include the XTRAC^®, XTRAC Momentum™ 1.0 and Pharos^® excimer lasers, VTRAC^® lamp systems, and TheraClear^® treatment systems utilized in the treatment of psoriasis, vitiligo, acne and various other skin conditions.

The Company’s proprietary XTRAC^® and XTRAC Momentum™ 1.0 excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone. In addition, STRATA's TheraClear^®X, utilizes FDA-Cleared technology to address the estimated $5.5 billion market opportunity for acne treatment with a non-invasive, highly effective, in-office procedure.

STRATA’s unique business model, in the U.S., leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.

Investor Contact
Jack Droogan
203-585-4140
ir@strataskin.com

FAQ

When is STRATA Skin Sciences presenting at the Gilmartin Group Showcase?

STRATA Skin Sciences will present on August 31, 2022, at 3:30 PM ET.

How can I watch the STRATA Skin Sciences presentation?

You can access the live webcast of the presentation through a link provided in the press release.

What products does STRATA Skin Sciences offer?

STRATA offers products like XTRAC, XTRAC Momentum 1.0, and TheraClear for treating dermatologic conditions.

What is the market opportunity for STRATA Skin Sciences' acne treatment?

The market opportunity for STRATA's acne treatment technology is estimated to be $5.5 billion.

What conditions does STRATA Skin Sciences target with its products?

STRATA targets conditions such as psoriasis, vitiligo, eczema, and acne.